Ramsay Sime Darby Picks Banks for $300 Milllion IPO
(Bloomberg) -- Ramsay Sime Darby Health Care Sdn. has picked arrangers for an initial public offering in Malaysia that could raise about $300 million, according to people with knowledge of the matter.
Credit Suisse Group AG, Malayan Banking Bhd. and Morgan Stanley have been chosen to work on the planned listing of the health care firm, said the people, who asked not to be identified as the information is private. The share sale in Kuala Lumpur could take place as soon as the second half of this year, the people said.
Ramsay Sime could add more banks to the lineup later, the people said. Deliberations are ongoing and hence details of the offering including size and timeline could still change, they said.
The mandates follow Malaysian conglomerate Sime Darby Bhd.'s earlier discussions with potential advisers for spinoff plans of the health care unit that it jointly owns with Australia's largest private hospital operator Ramsay Health Care Ltd., Bloomberg News reported in October.
Ramsay Sime is in the process of appointing several financial advisers for a preliminary review of strategic options, a representative for Sime Darby said in response to Bloomberg News query on Monday. Representatives for Credit Suisse, Maybank and Morgan Stanley declined to comment.
An offering could see the hospital operator joining glove makers Harps Holdings Sdn. and Smart Glove Corp. as well as property firm Iskandar Waterfront Holdings Sdn. in seeking to list in Malaysia this year. Companies raised about $487 million through first-time share sales in the Southeast Asian nation in 2020, up from $458 million a year earlier, according to data compiled by Bloomberg.
Ramsay Sime was set up in 2013 to hold Sime Darby and Ramsay Health's combined portfolio of hospitals in Southeast Asia. It operates six hospitals in Malaysia and Indonesia as well as a day surgery facility in Hong Kong, according to Sime Darby's annual report. The joint venture, which posted profit of 39 million ringgit ($9.6 million) in the financial year 2020, also runs a nursing college in Malaysia.
©2021 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
